XML 65 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
STATEMENTS OF CASH FLOWS (USD $)
12 Months Ended 89 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2012
Cash flows from operating activities      
Net loss $ (1,893,037) $ (4,884,786) $ (46,708,017)
Adjustment to reconcile net loss to net cash used in operating activities      
Depreciation and amortization 6,256 7,507 326,904
Stock-based compensation 312,690 806,327 10,618,150
Warrant liability (548,512) 0 (548,512)
Write-off of intangible assets 0 0 106,830
Warrants issued in connection with note conversion 0 0 288,000
Note discount arising from beneficial conversion feature 0 0 483,463
Loss on disposal of assets 0 1,501 36,724
Noncash interest expense 0 0 351,165
Changes in operating assets and liabilities      
Prepaid expenses and other current assets 146,386 (52,203) (124,912)
Other non-current assets 0 0 (51,938)
Accounts payable (254,921) 105,457 182,916
Accrued expenses and other current liabilities 67,210 (587,557) 131,928
Due to related party (22,753) (45,538) 16,139
Net cash used in operating activities (2,186,681) (4,649,292) (34,891,160)
Cash flows from investing activities      
Purchase of property and equipment 0 (1,987) (130,855)
Proceeds from sale of assets 0 0 2,500
Cash paid for intangible assets 0 0 (345,591)
Net cash used in investing activities 0 (1,987) (473,946)
Cash flows from financing activities      
Proceeds from issuance of notes payable 0 0 5,500,000
Repayment of notes payable 0 0 (1,500,000)
Proceeds from exercise of stock options and warrants 0 13,748 237,428
Proceeds from sale of common stock to founders 0 0 5,000
Proceeds from sale of common stock in private placement, net 1,194,207 2,298,566 31,169,394
Net cash provided by financing activities 1,194,207 2,312,314 35,411,822
Net (decrease) increase in cash and cash equivalents (992,474) (2,338,965) 46,716
Cash and cash equivalents at beginning of period 1,039,190 3,378,155  
Cash and cash equivalents at end of period 46,716 1,039,190 46,716
Supplemental schedule of cash flows information:      
Cash paid for interest 0 0 150,000
Supplemental schedule of non-cash investing and financing activities:      
Warrants issued in satisfaction of accrued liability 0 0 334,992
Warrants issued to placement agent and investors in connection with private placements   1,083,700 5,721,000
Warrants issued to investors in connection with registered direct offering 611,896 0 611,896
Conversion of notes payable and interest to common stock 0 0 4,351,165
Common shares of SMI issued in reverse merger transaction $ 0 $ 0 $ 1,250